Galmed Pharmaceuticals Ltd. Ordinary Shares (NASDAQ: GLMD) last traded at $4.31, down 5.59% on the session. The quote above updates while this page is open; the figures below are drawn from Galmed Pharmaceuticals Ltd. Ordinary Shares’s own filings and are restated only when a new one is published.
Galmed Pharmaceuticals Ltd. Ordinary Shares trades on NASDAQ under the ticker GLMD. Its market capitalisation is $28.33 million.
Valuation measures for Galmed Pharmaceuticals Ltd. Ordinary Shares, derived from the latest quote and its most recent SEC filing.
| Market cap | $28.33M |
|---|---|
| P/E ratio | 1.80 |
| Price / book | 1.80 |
| Beta | 0.83 |
Trailing-twelve-month figures tagged in Galmed Pharmaceuticals Ltd. Ordinary Shares's XBRL filings with the SEC.
| Net income (TTM) | -$10.31M |
|---|---|
| EPS (TTM) | $2.39 |
| Return on equity | -65.32% |
| Cash | $3.98M |
Range and volume for GLMD over the past 52 weeks.
| 52-week high | $13.20 |
|---|---|
| 52-week low | $3.29 |
| Volume | 21.4K |
| Average volume | 733.9K |
| Previous close | $4.56 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.